Sandoz Raised Its 2024 Net Sales Growth Guidance To High-Single Digits In Constant Currency; Maintains Core EBITDA Margin Guidance At ~20%
Portfolio Pulse from Benzinga Newsdesk
Sandoz has raised its 2024 net sales growth guidance to high-single digits in constant currency, driven by strong biosimilars and generics demand. The company maintains its core EBITDA margin guidance at approximately 20%.
October 30, 2024 | 6:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sandoz has increased its 2024 net sales growth guidance to high-single digits due to strong biosimilars and generics demand, while maintaining its core EBITDA margin guidance at ~20%.
The increase in sales growth guidance indicates positive business momentum, particularly in biosimilars and generics, which are key growth areas for Sandoz. Maintaining the EBITDA margin guidance suggests stable profitability. This news is likely to positively impact SDZNY's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100